While the AstraZeneca vaccine is accepted, Covishield is not accepted on the EU travel list. Covishield is the Indian manufactured, AstraZeneca vaccine, by Serum Institute India (SII) in Pune, India. The European Medicines Agency (EMA) has not approved this vaccine but the CEO of SII, Adar Poonawalla is contesting this.
Poonawalla has said, “I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries.”
The vaccine has, however, been approved by World Health Organization (WHO) and United Kingdom’s Medicines and Healthcare products Regulatory Agency (UKMHRA).
Many countries had started issuing visas for Indians, like Poland, Germany, Denmark, Belgium, Croatia, and Greece. In lieu of the EU not approving Covishield, new rules and restrictions for travel are awaited.
Earlier the EU had raised doubts about the Indian vaccine, Covaxin. But, earlier in June, the EMA had left many of the decisions on individual countries to decide which vaccines were accepted.